Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patients
Journal of Gynecologic Oncology · 2025
DOI: 10.3802/jgo.2025.36.e104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2025. Verfasst von Shoko Kitazawa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Medroxyprogesterone Acetate, Fertility Preservation, Endometrial Hyperplasia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
OBJECTIVE: Medroxyprogesterone acetate (MPA) is an effective fertility-preserving treatment for early endometrial cancer and atypical endometrial hyperplasia (AEH), and rarely leads to the development of extrauterine lesions (ELs). We aimed to clarify the characteristics of patients who developed ELs post-MPA therapy. METHODS: We analyzed the clinicopathological factors and prognoses of 319 patients with endometrioid carcinoma grade 1 (EMG1) and AEH treated with MPA at our institution. All patients underwent imaging before MPA treatment to rule out ELs. RESULTS: Seven patients (2.2%) with EMG1 showed EL after MPA treatment. Two patients developed EL during the initial treatment, 2 during repeated treatment, and 3 during follow-up. Two patients had peritoneal dissemination, 3 had regional lymph node metastasis, 1 had distant metastasis at the Virchow lymph node, and 1 had ovarian metastasis. ELs were diagnosed using imaging tests in 6 patients and elevated tumor markers in 3 (overlapping) patients. One patient was diagnosed with ELs pathologically after hysterectomy. Upon EL diagnosis, patients underwent standard treatment, including hysterectomy and chemotherapy, that was followed by a diagnosis of EMG1 for 5, EMG2 for 1, and EMG3 for 1 patient. One patient died 15 months after start of therapy and another died 119 months post-treatment initiation, while the others have been survived. CONCLUSION: Only 2.2% of all patients developed ELs post-MPA treatment, but some cases were fatal. It is essential to conduct imaging tests and screen for tumor markers during and after MPA treatment regularly and also when cancer progression is suspected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan.
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan. k_sakai@keio.jp.
- Department of Pathology, Keio University School of Medicine, Tokyo, Japan.
- Center of Maternal-Fetal/Neonatal Medicine, Hiroshima University Hospital, Hiroshima, Japan.
- Department of Obstetrics and Gynecology, International University of Health and Welfare, Chiba, Japan.
ORCID-Profile: Shoko Kitazawa, Kensuke Sakai, Miho Kawaida, Tatsuyuki Chiyoda, Hiroshi Nishio, Kouji Banno, Nobuyuki Susumu, Wataru Yamagami
Zitieren
APA
Kitazawa, S., Sakai, K., Kawaida, M., Chiyoda, T., Nishio, H., Banno, K., Susumu, N., & Yamagami, W. (2025). Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patients. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2025.36.e104
Vancouver
Kitazawa S, Sakai K, Kawaida M, Chiyoda T, Nishio H, Banno K, et al. Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patients. Journal of Gynecologic Oncology. 2025. doi:10.3802/jgo.2025.36.e104
BibTeX
@article{Kitazawa2025,
author = {Kitazawa, Shoko and Sakai, Kensuke and Kawaida, Miho and Chiyoda, Tatsuyuki and Nishio, Hiroshi and Banno, Kouji and Susumu, Nobuyuki and Yamagami, Wataru},
title = {Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patients},
journal = {Journal of Gynecologic Oncology},
year = {2025},
doi = {10.3802/jgo.2025.36.e104}
}
EUVIMED